Apollo Global Management Valuation
Is APO1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of APO1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: APO1 * (MX$2141.95) is trading below our estimate of fair value (MX$5172.1)
Significantly Below Fair Value: APO1 * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for APO1 *?
Other financial metrics that can be useful for relative valuation.
What is APO1 *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$69.27b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | 1.6x |
Price to Earnings Ratio vs Peers
How does APO1 *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 16.6x | ||
INVEX A INVEX Controladora. de | 9.2x | n/a | Mex$13.4b |
GFMULTI O Grupo Financiero Multiva. de | 8.2x | n/a | Mex$5.4b |
BAJAJFINSV Bajaj Finserv | 36.6x | 24.1% | ₹3.0t |
FSR FirstRand | 12.4x | 12.1% | R466.8b |
APO1 * Apollo Global Management | 13x | 8.0% | Mex$69.3b |
Price-To-Earnings vs Peers: APO1 * is good value based on its Price-To-Earnings Ratio (13x) compared to the peer average (16.6x).
Price to Earnings Ratio vs Industry
How does APO1 *'s PE Ratio compare vs other companies in the South American Diversified Financial Industry?
Price-To-Earnings vs Industry: APO1 * is expensive based on its Price-To-Earnings Ratio (13x) compared to the South American Diversified Financial industry average (8.1x).
Price to Earnings Ratio vs Fair Ratio
What is APO1 *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 13x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate APO1 *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$2,141.95 | Mex$2,525.10 +17.9% | 7.7% | Mex$3,027.75 | Mex$2,196.60 | n/a | 15 |
Sep ’25 | n/a | Mex$2,508.15 0% | 8.0% | Mex$3,014.85 | Mex$2,187.24 | n/a | 14 |
Aug ’25 | n/a | Mex$2,470.70 0% | 5.9% | Mex$2,759.50 | Mex$2,215.11 | n/a | 13 |
Jul ’25 | n/a | Mex$2,306.96 0% | 7.0% | Mex$2,681.33 | Mex$2,056.91 | n/a | 13 |
Jun ’25 | n/a | Mex$2,100.22 0% | 5.9% | Mex$2,303.26 | Mex$1,882.96 | n/a | 13 |
May ’25 | n/a | Mex$2,105.37 0% | 5.8% | Mex$2,339.15 | Mex$1,912.30 | n/a | 13 |
Apr ’25 | n/a | Mex$1,998.34 0% | 6.3% | Mex$2,261.88 | Mex$1,796.20 | n/a | 13 |
Mar ’25 | n/a | Mex$2,022.47 0% | 4.7% | Mex$2,171.47 | Mex$1,846.61 | n/a | 14 |
Feb ’25 | n/a | Mex$1,845.22 0% | 5.7% | Mex$2,024.73 | Mex$1,664.39 | n/a | 13 |
Jan ’25 | n/a | Mex$1,733.96 0% | 7.4% | Mex$1,922.80 | Mex$1,527.94 | n/a | 12 |
Dec ’24 | Mex$1,595.70 | Mex$1,700.94 +6.6% | 6.1% | Mex$1,857.28 | Mex$1,530.53 | n/a | 11 |
Nov ’24 | n/a | Mex$1,761.93 0% | 5.3% | Mex$1,888.10 | Mex$1,603.11 | n/a | 12 |
Oct ’24 | n/a | Mex$1,681.69 0% | 5.5% | Mex$1,823.30 | Mex$1,542.79 | n/a | 13 |
Sep ’24 | n/a | Mex$1,619.44 0% | 5.8% | Mex$1,781.52 | Mex$1,473.18 | n/a | 13 |
Aug ’24 | n/a | Mex$1,440.31 0% | 4.4% | Mex$1,538.05 | Mex$1,304.00 | n/a | 13 |
Jul ’24 | n/a | Mex$1,337.22 0% | 8.7% | Mex$1,468.58 | Mex$1,109.97 | n/a | 13 |
Jun ’24 | Mex$1,157.55 | Mex$1,372.27 +18.5% | 8.2% | Mex$1,526.56 | Mex$1,153.80 | n/a | 13 |
May ’24 | n/a | Mex$1,356.57 0% | 7.8% | Mex$1,552.09 | Mex$1,209.18 | n/a | 12 |
Apr ’24 | n/a | Mex$1,397.36 0% | 8.9% | Mex$1,603.92 | Mex$1,221.17 | n/a | 12 |
Mar ’24 | n/a | Mex$1,430.23 0% | 8.7% | Mex$1,615.32 | Mex$1,229.85 | n/a | 12 |
Feb ’24 | Mex$1,320.19 | Mex$1,452.55 +10.0% | 9.1% | Mex$1,654.68 | Mex$1,259.81 | n/a | 12 |
Jan ’24 | Mex$1,192.33 | Mex$1,437.53 +20.6% | 13.5% | Mex$1,742.87 | Mex$1,069.49 | n/a | 12 |
Dec ’23 | Mex$1,192.33 | Mex$1,360.83 +14.1% | 13.3% | Mex$1,673.39 | Mex$1,038.66 | Mex$1,595.70 | 12 |
Nov ’23 | Mex$1,192.33 | Mex$1,312.38 +10.1% | 15.0% | Mex$1,749.33 | Mex$1,085.79 | n/a | 13 |
Oct ’23 | Mex$1,192.33 | Mex$1,401.30 +17.5% | 13.2% | Mex$1,752.05 | Mex$1,168.03 | n/a | 12 |
Sep ’23 | Mex$1,192.33 | Mex$1,408.18 +18.1% | 13.2% | Mex$1,752.26 | Mex$1,168.17 | n/a | 12 |
Analyst Forecast: Target price is less than 20% higher than the current share price.